Steve Cashman Appointed Chief Business Officer at Butterfly Network

Butterfly Network Inc. has welcomed Steve Cashman to its C-Suite, naming him chief business officer (CBO) to lead global sales, marketing, and product/corporate strategy.

Cashman’s appointment follows the successful launch of the company’s third-generation Butterfly iQ3 in the United States. 

“The addition of Steve Cashman to our management team is another key marker of an outstanding 2024 for Butterfly,” Butterfly Network Board Chairman/President/CEO Joseph DeVivo said. “Steve joins us with profound knowledge of the ultrasound market, deep connection in the artificial intelligence space, and a thorough understanding of Butterfly’s technology. I’ve witnessed Steve’s strategic acumen and capacity for driving growth and innovation firsthand, and I’m beyond confident that he will be a major asset to us as we continue to enhance our commercial activities and deliver on our product roadmap.”
 
Cashman has built a reputation in the healthcare industry for his extensive health technology expertise, commercial leadership, and strategic foresight. Most recently, he was president and CEO of Caption Health, where he led the company through the development and commercialization of the industry’s first artificial intelligence-powered ultrasound platform, culminating in its acquisition by GE Healthcare. Prior to that, Cashman was chief commercial officer at InTouch Health through its acquisition by Teladoc, where he significantly expanded the company’s global footprint and drove key initiatives across product, marketing, and customer service.
 
Earlier in his career, Cashman was CEO of HealthSpot, a telehealth company acquired by Rite Aid, among other leadership and board positions. He is engaged in the startup community as a seasoned entrepreneur and angel investor, and is currently on the boards of Sovato, TympaHealth Technologies, Vista.ai, and PatientGenie.
 
“Joining Butterfly Network at this moment is incredibly exciting. I’m a firm believer in technology’s potential to enhance patient care and expand access to healthcare,” Cashman stated. “Butterfly has what it takes to drive the industry forward—it’s the right technology with the right approach. I’m eager to bring a fresh values-driven mindset and customer-first approach to the company. Together with the Butterfly team, I look forward to driving meaningful progress in the field and in our performance. The opportunity to make imaging happen earlier in the care journey has the potential to improve quality and make healthcare more equitable.”
 
Founded by Dr. Jonathan Rothberg in 2011, Butterfly Network is a digital health company with a mission to democratize medical imaging by making high-quality ultrasound affordable, easy-to-use, globally accessible, and intelligently connected, including for the 4.7 billion people around the world lacking access to ultrasound. Butterfly created the world’s first handheld single-probe whole-body ultrasound system using semiconductor technology, Butterfly iQ. The company launched its second-generation Butterfly iQ+ in 2020 and third-generation iQ3 in 2024—each with increased processing power and performance enhancements. The technology has been recognized by TIME’s Best Inventions, Fast Company’s World Changing Ideas, CNBC Disruptor 50, and MedTech Breakthrough Awards, among other accolades. With its proprietary Ultrasound-on-Chip technology, intelligent software, and educational offerings, Butterfly is paving the way to mass adoption of ultrasound for earlier detection and remote management of health conditions worldwide. Butterfly devices are commercially available to trained healthcare practitioners in areas including but not limited to parts of Africa, Asia, Australia, Europe, the Middle East, North America, and South America.